nutrients-logo

Journal Browser

Journal Browser

The Gut Microbiota at the Crossroads of Chronic Disease: Biological Functions, Disruptions, and Innovations in Therapy

A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Prebiotics, Probiotics and Postbiotics".

Deadline for manuscript submissions: 25 June 2026 | Viewed by 1255

Special Issue Editors


E-Mail Website
Guest Editor
Division of Food Science, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Tuwima 10, 10-748 Olsztyn, Poland
Interests: microbiota; microbiome; immune system; intestine; bioactive compounds; food; nutrition; inflammation; food allergy
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Division of Food Science, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Tuwima 10, 10-748 Olsztyn, Poland
Interests: in vivo experiments; nutrition; oxidative stress; inflammation; obesity; liver disorders; gut-microbiota-derived metabolites; metabolic disorders; interaction between the gut and liver
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Growing evidence shows that the gut microbiota and the bioactive metabolites it produces are central to human physiology. Disturbances in microbial composition and function are increasingly recognized as contributors to the development and progression of chronic conditions, including metabolic syndrome, autoimmune disorders, neurodegenerative diseases, and mood-related pathologies. These imbalances arise from a combination of genetic predispositions, dietary patterns, environmental exposures, and ageing.

The past decade has seen remarkable advances in microbiome science, revealing how microbial communities regulate host immunity, inflammation, nutrient metabolism, and gut barrier integrity. Disruptions in these processes can initiate systemic effects, influencing distant organs through mechanisms such as the gut–brain axis, gut–liver crosstalk, and immune modulation. Understanding these pathways opens the door to novel dietary, microbiota-targeted, and personalized interventions for chronic disease prevention and management.

This Special Issue welcomes contributions that deepen our understanding of how dietary and nutritional factors affect the gut microbiota and the onset and progression of chronic diseases. We encourage submissions that explore microbial metabolites, host–microbe interactions, microbiome-modulating strategies, and translational approaches with clinical or nutritional relevance. Both original research articles and comprehensive reviews are invited.

We look forward to your contributions to advancing this dynamic field.

Dr. Joanna Fotschki
Dr. Bartosz Fotschki
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gut microbiota
  • dysbiosis
  • intestinal bacteria
  • chronic diseases
  • gut–brain axis
  • probiotics
  • prebiotics
  • psychobiotics
  • metabolic disorders
  • autoimmune disorders
  • immune response
  • dietary interventions

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

23 pages, 3298 KB  
Article
Dietary Fibre Modulates Gut Microbiota Responses to Copper Nanoparticles
by Bartosz Fotschki, Dorota Napiórkowska, Joanna Fotschki, Kamil Myszczyński, Ewelina Cholewińska, Katarzyna Ognik and Jerzy Juśkiewicz
Nutrients 2026, 18(5), 828; https://doi.org/10.3390/nu18050828 - 3 Mar 2026
Viewed by 404
Abstract
Background/Objectives: Although copper nanoparticles (Cu-NPs) are increasingly explored as food and feed additives, there is still limited evidence on how the commonly consumed dietary fibre matrix modulates their effects on the gut microbiota. This study evaluated whether different dietary fibres (cellulose, pectin, inulin, [...] Read more.
Background/Objectives: Although copper nanoparticles (Cu-NPs) are increasingly explored as food and feed additives, there is still limited evidence on how the commonly consumed dietary fibre matrix modulates their effects on the gut microbiota. This study evaluated whether different dietary fibres (cellulose, pectin, inulin, psyllium) modulate Cu-NP–driven changes in caecal microbiota activity, composition, and bile acid metabolism in rats in a multifactorial design accounting for fibre type, copper dose, and copper form. Methods: Wistar male rats (n = 10 per group, 10 groups) were fed semi-purified diets for 6 weeks. Cu-NPs were provided at 6.5 or 13 mg Cu/kg diet and combined with cellulose (control fibre) or with pectin, inulin, or psyllium. Caecal digesta parameters, microbial enzyme activities, short-chain fatty acids (SCFAs), bile acids, and 16S rRNA sequencing were used to assess microbial diversity. Results: Final body weight did not differ among groups, whereas feed intake decreased most consistently with inulin and psyllium. Inulin and psyllium increased caecal digesta and tissue mass, while pectin increased caecal ammonia. Higher Cu-NPs dose reduced several microbial enzyme activities and lowered major SCFAs across most treatments; pectin most strongly preserved/enhanced glycosidase activities and was associated with increased SCFA levels vs. control, with a 32% rise in acetate, a 47% rise in propionate, and a 61% rise in butyrate. Fibre type dominated bile acid outcomes: psyllium reduced total bile acids by 11.8% vs. control, while inulin increased muricholic acids by 216% vs. control. Microbiota alpha and beta diversity separated primarily by fibre type, with distinct clustering particularly in pectin-fed groups. Across comparisons, Mucispirillum was consistently reduced in fibre-supplemented groups vs. cellulose, alongside recurrent changes in selected genera; functional profiling highlighted shared shifts in carbohydrate, fermentation, transport, and stress-response features under Cu-NPs exposure. Conclusions: The gastrointestinal and microbiota responses to Cu-NPs are strongly fibre-dependent; thus, Cu-NP safety and functionality should be evaluated together with the accompanying dietary fibre matrix, not as a standalone exposure. Implications for humans remain indirect and require confirmation in human-relevant models and clinical settings. Full article
Show Figures

Figure 1

Review

Jump to: Research

43 pages, 2170 KB  
Review
The Gut Gambit: A Review of How Microbial Imbalance Fuels Metabolic Mayhem
by Lakshmayya Nunna Sai Venkata, Awdhesh Kumar Mishra, Yugal Kishore Mohanta, Sarvesh Rustagi, Ashutosh Bahuguna, Anjali Tomar, Kwang-Hyun Baek and Bishwambhar Mishra
Nutrients 2026, 18(6), 888; https://doi.org/10.3390/nu18060888 - 11 Mar 2026
Viewed by 576
Abstract
Background/Objectives: An imbalance in gut microbiota, known as gut dysbiosis, results in reactive oxygen species overproduction, which can cause inflammatory conditions, damage DNA, trigger immunity, and induce epigenetic modifications of crucial genes that regulate metabolic pathways. Such a condition can also weaken the [...] Read more.
Background/Objectives: An imbalance in gut microbiota, known as gut dysbiosis, results in reactive oxygen species overproduction, which can cause inflammatory conditions, damage DNA, trigger immunity, and induce epigenetic modifications of crucial genes that regulate metabolic pathways. Such a condition can also weaken the resilience of the protective gut wall and elevate colon permeability, allowing toxins from the gut to reach the liver and bloodstream, contributing to oxidative damage, autoimmune diseases, and epigenetic changes linked to metabolic disorders. Methods: The Scopus database was exclusively searched for the literature. Relevant articles were identified using predefined keywords, including gut dysbiosis, microbiota, microbiome, oxidative stress, metabolic disorders, inflammation, and epigenetics or combinations. Gut microbiota- and diet-induced metabolic disorders, particularly obesity, insulin resistance, dyslipidemia, and hypertension, may be inherited through epigenetic pathways. Results: The evidence analyzed suggests that the gut microbiota serves as a diverse metabolic and immunological organ. Its disruption affects the production of short-chain fatty acids, bile acid metabolism, immune signaling, and the redox balance, which contributes to the development of obesity, insulin resistance, and metabolic syndrome. Conclusions: This review highlights key epigenetic mechanisms underlying metabolic disorders and oxidative stress in the context of gut dysbiosis. Furthermore, therapeutic strategies targeting the gut microbiota, such as dietary interventions, prebiotics, probiotics, postbiotics, and fecal microbiota transplantation, hold promise for mitigating oxidative stress and inflammation associated with metabolic syndrome. Full article
Show Figures

Figure 1

Back to TopTop